Detalhe da pesquisa
1.
Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers.
Eur J Med Chem
; 250: 115175, 2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780833
2.
Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia.
Eur J Med Chem
; 221: 113522, 2021 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33984804
3.
Corrigendum to "Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia" [Eur. J. Med. Chem. 221 (2021) 113522].
Eur J Med Chem
; 228: 114041, 2022 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902733